Association between testicular dysgenesis syndrome (TDS) and testicular neoplasia: Evidence from 20 adult patients with signs of maldevelopment of the testis

APMIS

Volumn 111, Issue 1, 2003, Pages 1-11

  Skakkebæk, Niels E ^a   Holm, Mette ^a   Hoei Hansen, Christina ^a   Jørgensen, Niels ^a   Rajpert De Meyts, Ewa ^a   Mayer, Frank ^b   Chemes, Hector ^b   Oliver, Tim ^b   Bokemeyer, Carsten ^b   Oosterhuis, J Wolter ^b   Dieckmann, Klaus Peter ^b   Vogt, Peter ^b  

^a Rigshospitalet   (Denmark)

^b Section GR 5064 ^*

Author keywords

Carcinoma in situ; Cryptorchidism; Male infertility; Testicular dysgenesis syndrome; Testicular neoplasm

Indexed keywords

SEX HORMONE;

ADOLESCENT; ADULT; AZOOSPERMIA; CANCER CELL; CANCER DIAGNOSIS; CARCINOMA IN SITU; CELL DIFFERENTIATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; CRYPTORCHISM; DATA ANALYSIS; DEL CASTILLO SYNDROME; DISEASE ASSOCIATION; GENITAL MALFORMATION; GERM CELL TUMOR; GONADAL DYSGENESIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOTHESIS; MALE; MALE INFERTILITY; MEDICAL RECORD; OLIGOSPERMIA; PRIORITY JOURNAL; SEMEN ANALYSIS; SEMINIFEROUS TUBULE; SERTOLI CELL; SPERMATOGENESIS; SUBFERTILITY; TESTIS BIOPSY; TESTIS CANCER; TESTIS DEVELOPMENT; TESTIS TUMOR;

ADOLESCENT; ADULT; BIOPSY; CARCINOMA IN SITU; CRYPTORCHIDISM; DATABASES, FACTUAL; GONADAL DYSGENESIS; HUMANS; HYPOSPADIAS; INFERTILITY; MALE; NEOPLASMS, GERM CELL AND EMBRYONAL; OLIGOSPERMIA; SYNDROME; TESTICULAR NEOPLASMS; TESTIS;

EID: 0038222522     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0463.2003.11101031.x     Document Type: Conference Paper

References (43)

1. Skakkebæk NE, Berthelsen JG, Giwercman A, Müller J. Carcinoma-in-situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma. Int J Androl 1987;10:19-28.
2. Rajpert-De Meyts E, Jørgensen N, Brøndum-Nielsen K, Müller J, Skakkebæk NE. Developmental arrest of germ cells in the pathogenesis of germ cell neoplasia. APMIS 1998;106:198-206.
3. Andrews PW, Casper J, Damjanov I, Duggan MB, Giwercman A, Hata J, et al. Comparative analysis of cell surface antigens expressed by cell lines derived from human germ cell tumours. Int J Cancer 1996;66:806-16.
4. Rørth M, Rajpert-De Meyts E, Andersson L, Dieckmann K-P, Fosså SD, Grigor KM, et al. Carcinoma in situ in the testis. Scand J Urol Nephrol 2000;205:166-86.
5. Giwercman A, Bruun E, Frimodt-Møller C, Skakkebæk NE. Prevalence of carcinoma in situ and other histopathological abnormalities in testes of men with a history of cryptorchidism. J Urol 1989;142:998-1002.
6. Prener A, Engholm G, Jensen OM. Genital anomalies and risk for testicular cancer in Danish men. Epidemiology 1996;7(1):14-9.
7. Møller H. Epidemiological studies of testicular germ cell cancer. University of Copenhagen, 2000 (doctoral dissertation).
8. Berthelsen JG, Skakkebæk NE. Gonadal function in men with testis cancer. Fertil Steril 1983;39:68-75.
9. Møller H, Skakkebæk NE. Risk of testicular cancer in subfertile men: case-control study. Br Med J 1999;318:559-62.
10. Jacobsen R, Bostofte E, Engholm G, Hansen J, Skakkebæk NE, Møller H. Fertility and offspring sex ratio of men who develop testicular cancer: a record linkage study. Hum Reprod 2000;15:1958-61.
11. Skakkebæk NE, Rajpert-De Meyts E, Main KM. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum Reprod 2001;16:972-8.
12. Hoei-Hansen CE, Holm M, Rajpert-De Meyts E, Skakkebæk NE. Histological evidence of testicular dysgenesis in contralateral biopsies from 218 patients with testicular germ cell cancer. J Pathol. 2003 - In press.
13. Bruun E, Frimodt-Møller C, Giwercman A, Lenz S, Skakkebæk NE. Testicular biopsy as an outpatient procedure in screening for carcinoma-in-situ: complications and the patient's acceptance. Int J Androl 1987;10:199-202.
14. Giwercman A, Berthelsen JG, Müller J, von der Maase H, Skakkebæk NE. Screening for carcinoma-in-situ of the testis. Int J Androl 1987;10:173-80.
15. Beckstead JH. Alkaline phosphatase histochemistry in human germ cell neoplasms. Am J Surg Pathol 1983;7:341-9.
16. Jacobsen GK, Nørgaard-Pedersen B. Placental alkaline phosphatase in testicular germ cell tumours and in carcinoma-in-situ of the testis. APMIS 1984;92:323-9.
17. Jørgensen N, Auger J, Giwercman A, Irvine DS, Jensen TK, Jouannet P, et al. Semen analysis performed by different laboratory teams: an intervariation study. Int J Androl 1997;20:201-8.
18. Jørgensen N, Andersen A-G, Eustache F, Irvine DS, Suominen J, Petersen JH, et al. Regional differences in semen quality in Europe. Hum Reprod 2001;16:1012-9.
19. Jensen TK, Andersson A-M, Hjollund NHI, Scheike T, Kolstad H, Giwercman A, et al. Inhibin B as a serum marker of spermatogenesis: correlation to differences in sperm concentration and follicle-stimulating hormone levels. A study of 349 Danish men. J Clin Endocrinol Metab 1997;82:4059-64.
20. Anawalt BD, Bebb RA, Matsumoto AM, Groome NP, Illingworth PJ, McNeilly AS, et al. Serum inhibin B levels reflect Sertoli cell function in normal men and men with testicular dysfunction. J Clin Endocrinol Metab 1996;81:3341-5.
21. von Eckardstein S, Simoni M, Bergmann M, Weinbauer GF, Gassner P, Schepers AG, et al. Serum inhibin B in combination with serum follicle-stimulating hormone (FSH) is a more sensitive marker than serum FSH alone for impaired spermatogenesis in men, but cannot predict the presence of sperm in testicular tissue samples. J Clin Endocrinol Metab 1999;84:2496-501.
22. Andersson A-M. Inhibin B in the assessment of seminiferous tubular function. Baillieres Clin Endocrinol Metab 2000;14:389-97.
23. Anderson RA, Wallace EM, Groome NP, Bellis AJ, Wu FC. Physiological relationships between inhibin B, follicle stimulating hormone secretion and spermatogenesis in normal men and response to gonadotrophin suppression by exogenous testosterone. Hum Reprod 1997;12:746-51.
24. Weidner IS, Møller H, Jensen TK, Skakkebæk NE. Risk factors for cryptorchidism and hypospadias. J Urol 1999;161:1606-9.
25. Scully RE. Neoplasia associated with anomalous sexual development and abnormal sex chromosomes. Ped Adolesc Endocrinol 1981;8:203-17.
26. Chemes HE, Muzulin PM, Venara MC, del Carmen Muhlmann M, Martinez M, Gamboni M. Early manifestations of testicular dysgenesis in children: Pathological phenotypes, karyotype correlations and precursors stages of tumour development. APMIS 2003;111:12-24.
27. Kang J-L, Rajpert-De Meyts E, Giwercman A, Skakkebæk NE. The association of testicular carcinoma in situ with intratubular microcalcifications. J Urol Pathol 1994;2:235-42.
28. Ratcliffe SG, Bancroft J, Axworthy D, McLaren W. Klinefelters syndrome in adolescence. Arch Dis Child 1982;57:6-12.
29. Frydelund-Larsen L, Krausz C, Leffers H, Andersson A-M, Carlsen E, Bangsbøll S, et al. Inhibin B: a marker for the functional state of the seminiferous epithelium in patients with azoospermia factor c microdeletions. J Clin Endocrinol Metab 2002;87:5618-24.
30. Antonelli A, Gandini L, Petrinelli P, Marcucci L, Elli R, Lombardo F, et al. Chromosomal alterations and male infertility. J Endocrinol Invest 2000;23:677-83.
31. Cortes D, Thorup JM, Beck BL. Quantitative histology of germ cells in the undescended testes of human fetuses, neonates and infants. J Urol 1995;154:1188-92.
32. Turek PJ, Kim M, Gilbaugh JH, Lipshultz LI. The clinical characteristics of 82 patients with Sertoli cell-only testis histology. Fertil Steril 1995;64:1197-200.
33. Nistal M, Riestra ML, Paniagua R. Correlation between testicular biopsies (prepubertal and postpubertal) and spermiogram in cryptorchid men. Hum Pathol 2000;31:1022-30.
34. Olesen H. Morfologiske sperma- og testisundersøgelser. Munksgård 1948.
35. Giwercman A, Müller J, Skakkebæk NE. Prevalence of carcinoma-in-situ and other histopathological abnormalities in testes from 399 men who died suddenly and unexpectedly. J Urol 1991;145:77-80.
36. Sohval AR. Testicular dysgenesis as an etiologic factor in cryptorchidism. J Urol 1954;72:693-702.
37. Sohval AR. Testicular dysgenesis in relations to neoplasm of the testicle. J Urol 1956;75:285-91.
38. Parkinson MC, Harland SJ, Harnden P, Sandison A. The role of the histopathologist in the management of testicular germ cell tumour in adults. Histopathology 2001;38:183-94.
39. Adami H-O, Bergström R, Möhner M, Zatonski W, Storm H, Ekbom A, et al. Testicular cancer in nine Northern European countries. Int J Cancer 1994;59:33-8.
40. Toppari J, Kaleva M, Virtanen HE. Trends in the incidence of cryptorchidism and hypospadias, and methodological limitations of registry-based data. Hum Reprod Update 2001;7:282-6.
41. Andersen AG, Jensen TK, Carlsen E, Jørgensen N, Andersson A-M, Krarup T, et al. High frequency of sub-optimal semen quality in an unselected population of young men. Hum Reprod 2000;15:366-72.
42. Jørgensen N, Carlsen E, Nermoen I, Punab M, Suominen J, Andersen A-G, et al. East-West gradient in semen quality in the Nordic-Baltic area: a study of men from the general population in Denmark, Norway, Estonia and Finland. Hum Reprod 2002;17:2199-208.
43. Holzik MFL, Sijmons RH, Sleijfer DT. Sonneveld DJA, Hoekstra-Weebers JEHM, van Echten-Arends J et al. Syndromic aspects of testicular carcinoma. Cancer 2003;97:984-92.